Principal Financial Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-68,620
Closed -$1.95M 2519
2023
Q1
$1.95M Sell
68,620
-2,285
-3% -$64.8K ﹤0.01% 1768
2022
Q4
$2.07M Sell
70,905
-384
-0.5% -$11.2K ﹤0.01% 1756
2022
Q3
$1.88M Sell
71,289
-10,970
-13% -$290K ﹤0.01% 1721
2022
Q2
$3.66M Sell
82,259
-936
-1% -$41.6K ﹤0.01% 1660
2022
Q1
$4.12M Sell
83,195
-4,702
-5% -$233K ﹤0.01% 1724
2021
Q4
$4.48M Sell
87,897
-10,719
-11% -$546K ﹤0.01% 1707
2021
Q3
$5.5M Sell
98,616
-2,370
-2% -$132K ﹤0.01% 1654
2021
Q2
$4.32M Sell
100,986
-9,653
-9% -$413K ﹤0.01% 1752
2021
Q1
$4.62M Buy
110,639
+2,286
+2% +$95.4K ﹤0.01% 1687
2020
Q4
$5.05M Buy
108,353
+1,022
+1% +$47.6K ﹤0.01% 1555
2020
Q3
$4.56M Buy
107,331
+20,781
+24% +$883K ﹤0.01% 1487
2020
Q2
$4.15M Sell
86,550
-249
-0.3% -$11.9K ﹤0.01% 1498
2020
Q1
$3.99M Sell
86,799
-3,131
-3% -$144K ﹤0.01% 1376
2019
Q4
$5.4M Buy
89,930
+10,160
+13% +$610K ﹤0.01% 1512
2019
Q3
$4.51M Sell
79,770
-2,869
-3% -$162K ﹤0.01% 1551
2019
Q2
$4.6M Sell
82,639
-162
-0.2% -$9.02K ﹤0.01% 1556
2019
Q1
$4.18M Sell
82,801
-6,488
-7% -$328K ﹤0.01% 1604
2018
Q4
$3.6M Sell
89,289
-669
-0.7% -$27K ﹤0.01% 1600
2018
Q3
$6.24M Buy
89,958
+25,120
+39% +$1.74M 0.01% 1533
2018
Q2
$4.91M Sell
64,838
-9,047
-12% -$685K ﹤0.01% 1599
2018
Q1
$3.89M Buy
73,885
+2,436
+3% +$128K ﹤0.01% 1626
2017
Q4
$3.82M Sell
71,449
-1,504
-2% -$80.3K ﹤0.01% 1638
2017
Q3
$4.35M Buy
72,953
+4,963
+7% +$296K ﹤0.01% 1595
2017
Q2
$5.36M Buy
67,990
+5,954
+10% +$470K 0.01% 1526
2017
Q1
$5.15M Buy
62,036
+3,879
+7% +$322K 0.01% 1522
2016
Q4
$4.61M Buy
58,157
+19
+0% +$1.51K 0.01% 1541
2016
Q3
$4.07M Buy
+58,138
New +$4.07M 0.01% 1525